Project Grant H8G47880

This $199,295 National Science Foundation project grant funded the development of a comparative online simulation tool for COVID-19 vaccine allocation strategies. Funded under the Biological Sciences program (CFDA 47.074), the Fred Hutchinson Cancer Research Center will create a mathematical model of SARS-CoV-2 transmission incorporating multiple vaccines, viral variants, and demographic factors. This model will then be used to develop a free, open-source, online comparative tool allowing up...

The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...

The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...

This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $2,065,719 to New York University to conduct a community-based behavioral intervention study. The goal is to increase COVID-19 and influenza vaccination rates among African American/Black and Latino persons, populations that have experienced disparities in vaccination uptake. The study will test the impact of four intervention...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $282,526 Cooperative Agreement to the South Carolina Department of Public Health (SCDPH) under the Immunization Cooperative Agreements (CFDA 93.268) program. The award, effective August 1, 2024 through July 31, 2029, will support SCDPH in establishing and maintaining preventive health service programs to immunize individuals against vaccine-preventable diseases such as measles, poliomyelitis,...

This federal Project Grant award of $1,266,296 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to model the impact of minor vaccine consent (VC) laws on COVID-19 vaccine uptake and transmission among adolescents. The research team at the University of Pittsburgh will develop a comprehensive legal dataset of state and local VC laws, collaborate with community...

This $799,904 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program supports the "ARISE COORDINATING AND COLLABORATING CENTERS FOR THE STUDY OF VACCINE HESITANCY AND UPTAKE" project at New York University (NYU) School of Medicine. The project aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious...

The Massachusetts Department of Public Health (MDPH) was awarded a $1,753,605.00 Cooperative Agreement under the Immunization Cooperative Agreements (CFDA 93.268) program administered by the U.S. Centers for Disease Control and Prevention (CDC). This 5-year award, effective August 1, 2024 through July 31, 2029, will support MDPH's efforts to establish and maintain preventive health service programs focused on immunization against vaccine-preventable diseases. The award enables MDPH to deliver...

The Hawaii Department of Health received a $5,358,220 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program. The award will fund the establishment and maintenance of a workgroup within the department to increase vaccination rates in Hawaii, with a focus on populations disproportionately affected by the MPOX outbreak. Key activities will include...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,250 to the University of Virginia to develop a vaccine against cryptosporidiosis, a common cause of diarrheal disease in Sub-Saharan Africa and Asia. The key objectives are to optimize the systemic and cellular immune responses to promising vaccine antigens, and to evaluate the protective efficacy of the optimal...